2021 ASCO Virtual Direct™ Highlights
2021 ASCO Key Takeaways on Kidney & Bladder Cancers: Immuno-oncology, Avelumab in mUC, Adjuvant Pembrolizumab Following Surgery in High-Risk ccRCC
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Joseph Kim
By
2021 ASCO Virtual Direct™ Highlights
FEATURING
Joseph Kim
Login to view comments.
Click here to Login